Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate

In previously performed animal studies and Phase I–II human trials, Bowman-Birk inhibitor concentrate (BBIC) appeared to be a promising cancer chemopreventive agent. The present study describes the results of two phase I randomized double-blind placebo-controlled trials performed in male subjects to...

Descripción completa

Detalles Bibliográficos
Autores principales: LIN, LILIE L., MICK, ROSEMARIE, WARE, JEFFREY, METZ, JAMES, LUSTIG, ROBERT, VAPIWALA, NEHA, RENGAN, RAMESH, KENNEDY, ANN R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961219/
https://www.ncbi.nlm.nih.gov/pubmed/24944684
http://dx.doi.org/10.3892/ol.2014.1855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961219/
https://www.ncbi.nlm.nih.gov/pubmed/24944684
http://dx.doi.org/10.3892/ol.2014.1855

Ejemplares similares